Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000622957 | SCV000742211 | uncertain significance | Inborn genetic diseases | 2019-05-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003151798 | SCV003840878 | likely pathogenic | not provided | 2024-11-25 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 33268356, 27535533) |
Illumina Laboratory Services, |
RCV005401534 | SCV006059815 | likely pathogenic | Bryant-Li-Bhoj neurodevelopmental syndrome 2 | 2024-06-21 | criteria provided, single submitter | clinical testing | The H3-3B c.119A>G p.(His40Arg) missense variant has been reported in a de novo state in an individual with Bryant-Li-Bhoj neurodevelopmental syndrome (BRYLIB). Additionally, a different amino acid substitution at the same codon in the H3-3A gene, which encodes an identical protein as H3-3B, has also been reported in a de novo state in an individual with BRYLIB (PMID: 33268356). This region is a hot spot in both the H3-3B and H3-3A genes (PMID: 33268356; 34876591). This variant is not observed in version 2.1.1 or version 4.1.0 of the Genome Aggregation Database. Based on the available evidence, the c.119A>G p.(His40Arg) variant is classified as likely pathogenic for Bryant-Li-Bhoj neurodevelopmental syndrome. |